← All candidates
Two insider buys in the last year — $225.0K in all.
16 filings on record.
XAIRBeyond Air, Inc.
NasdaqCM · Healthcare · $3.15M
$3.20
+4.23% · Sep 11
Two insider buys in the last year — $225.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys◆ 14 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what XAIR ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$3.15M
Float
0.8M
86% public
Short % float
Pro
Price / profit
0.0
Price / future profit
—
Price / sales
0.4
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Goodman Robert Scott
Bought $200.0K on Jul 29 — 34,722 sh @ $5.76, held direct, 100% of their stake.
First Form 4 on file
Chief Financial Officer
Moorhead Daniel J
Bought $25.0K on Jul 29 — 4,340 sh @ $5.76, held direct, 100% of their stake.
No completed positions to measure
CEO and Chairman of the Board
Lisi Steven A.
Bought $19.5K on Jul 21 — 6,000 sh @ $3.25, held direct, 0.2% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$160.00 avg target
+4900.0% vs today · 2 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q1 '26−$15.40 act−$4.07
Q4 '25−$17.00 act−$6.20
Q3 '25−$25.00 act−$19.80
Q2 '25−$30.60 act−$4.20
Coverage
Beyond Air, Inc. Q4 2026 Earnings Call SummaryMoby · 06-27Beyond Air (XAIR) Q4 2026 Earnings Call TranscriptMotley Fool · 06-27Beyond Air Inc (XAIR) Q4 2026 Earnings Call Highlights: Revenue Surge and Path to ProfitabilityGuruFocus.com · 06-26Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide TherapiesInsider Monkey · 03-04
The file stays open
16 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice